Nervecept® formula & order desk · Cycle 2026 · U.S. stock · Payment runs on the maker's BuyGoods checkout
Order Now • From $49
Methodology

Editorial Standards: How We Check Every Nervecept Fact

The sources we use, the lines we do not cross, and how to get a mistake corrected.

Updated October 16, 2026Matched to the bottle label

Where our facts come from

  1. The label: the Supplement Facts panel and label artwork published by the maker.
  2. The maker's pages: the sales page, the BuyGoods order page, the return policy, terms and contact pages.
  3. Primary research: peer-reviewed studies indexed in PubMed, linked by PMID, plus NIH, FDA and other government pages.

When sources disagree, we say so and show both, as with the two different start dates for the refund window.

Rules we follow

  • No invented testimonials, reviewer names, star ratings or review counts.
  • No fabricated lab results, certificate numbers, batch numbers or warehouse details.
  • No disease claims: Nervecept is described as a supplement, never as a treatment.
  • Every dose comparison links to the study it comes from.
  • Commercial relationship disclosed on every page.

Corrections

Send corrections to [email protected]. We check them against the source and, if we were wrong, fix the page and update the date.

How the site is funded

We earn a commission when a reader orders through our links. The commission does not change with the package size, and it does not buy a positive verdict: our editorial score includes the weak points as well as the strong ones.